Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by V Vihervaara
Productivity Costs Related to Bortezomib and Carfilzomib Administration for Multiple Myeloma in Finland
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Nelfinavir Augments Proteasome Inhibition by Bortezomib in Myeloma Cells and Overcomes Bortezomib and Carfilzomib Resistance
Blood Cancer Journal
Oncology
Hematology
Carfilzomib for Relapsed or Refractory Multiple Myeloma
The Lancet Oncology
Oncology
Bortezomib for the Treatment of Multiple Myeloma Patients
Health Technology Assessment
Medicine
Health Policy
Intravenous (IV) Bortezomib Infusion After Non-Response to Subcutaneous Bortezomib Administration Can Induce Transitory Responses in Multiple Myeloma Patients: Are Some Patients More Sensitive to IV Bortezomib?
British Journal of Haematology
Hematology
Emerging Treatments for Multiple Myeloma: Beyond Immunomodulatory Drugs and Bortezomib
Seminars in Hematology
Hematology
Home Administration of Bortezomib: Making a Difference to Myeloma Patients' Lives
European Journal of Oncology Nursing
Medicine
Oncology
Review New Drugs in Multiple Myeloma – Role of Carfilzomib and Pomalidomide
Wspolczesna Onkologia
Oncology
Radiology
Nuclear Medicine
Imaging
Intracellular Glutathione Determines Bortezomib Cytotoxicity in Multiple Myeloma Cells
Blood Cancer Journal
Oncology
Hematology
Bortezomib Induces Heme Oxygenase-1 Expression in Multiple Myeloma
Cell Cycle
Medicine
Developmental Biology
Cell Biology
Molecular Biology
